Oncogenic impact of human papilloma virus in head and neck cancer

Journal of Laryngology and Otology

Volumn 124, Issue 9, 2010, Pages 941-944

  Heffernan, C B ^a   O'Neill, J P ^a   Timon, C ^a  

^a ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

Head And Neck Neoplasms; Human Papilloma Virus; Pharynx Neoplasms; Squamous Carcinoma

Indexed keywords

WART VIRUS VACCINE;

ALCOHOL CONSUMPTION; CARCINOGENESIS; CIGARETTE SMOKING; HEAD AND NECK CANCER; HEALTH CARE PLANNING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; OROPHARYNX CANCER; PATHOPHYSIOLOGY; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS IDENTIFICATION;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MUCOUS MEMBRANE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; UTERINE CERVICAL NEOPLASMS;

EID: 78649931517     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215110001179     Document Type: Review

References (24)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and Neck Cancer. N Engl J Med 1993;328:184-94
2. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75
3. Hu D, Goldie SJ. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol 2008;198;487-8
4. Mineta H, Ogino T, Amano HM, Ohkawa Y, Araki K, Takebayashi S et al. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res 1998;18:4765-8
5. Franceschi S, Munoz N, Bosch XF, Snijders PJ,Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: A review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1995;5: 567-75
6. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004;57:449-55
7. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et al. Improved survival of patients with human papillomavirus- positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-9
8. Campisi G, Giovannelli L. Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol 2009;1:8
9. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX et al. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 1997; 71:2463-72
10. Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006;12:701-9
11. Chaudhary A, Singh M, Sundaram S, Mehrotra R. Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: Updated review. Head Neck Oncol 2009;1:22
12. Hafkamp HC, Speel EJ, Haesevoets A, Bot FJ, Dinjens WN, Ramaekers FC, Hopman AH, Manni JJ. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16 and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003;107:394-400
13. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-31
14. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002;8:3187-92
15. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-20
16. Giovannelli L, Campisi G, Lama A, Giambalvo O, Osborn J, Margiotta V et al. Human papillomavirus DNA in oral mucosal lesions. J Infect Dis 2002;185:833-6
17. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002;8:1203-9
18. Devaraj K, Gillison ML, Wu TC. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma. Crit Rev Oral Biol Med 2003;14: 345-62
19. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199: 1263-9
20. Gillison ML. Human papillomavirus-related diseases: Oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health 2008;43(suppl 1): S52-60
21. Yan J, Reichenbach DK, Corbitt N, Hokey DA, Ramanathan MP, McKinney KA et al. Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen. Vaccine 2009;27:431-40
22. Lee DW, Anderson ME,Wu S, Lee JH. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus- positive cancer. Arch Otolaryngol Head Neck Surg 2008;134:1316-23
23. Klozar J, Kratochvil V, Salakova M, Smahelova J, Vesela E, Hamsikova E et al. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 2008;265:S75-82
24. Mendenhall WM, Logan HL. Human papillomavirus and head and neck cancer. Am J Clin Oncol 2009 Jul 31. [Epub ahead of print]